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Abstract
The integration of information on different aspects of the composition and function of
mitochondria is defining a more comprehensive mitochondrial interactome and elucidating its
role in a multitude of cellular processes and human disease.
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Mitochondria are complex, dynamic and essential organelles
in eukaryotic cells. They are remarkable structures with
well-known functions, such as the production of ATP via
oxidative phosphorylation and a role in apoptosis. In
addition, they are now being implicated in novel cellular
functions (for example, oxygen sensing, signal transduction
and anti-viral mechanisms). Mitochondrial dysfunction is
also increasingly being shown to be relevant in disease, age-
related and environmentally induced pathology and the
aging process itself [1].
Mitochondria contain a DNA genome (mtDNA), clear
evidence of their past as a free-living bacterium, related to
the present-day α-proteobacteria, that became engulfed in
an ancestral eukaryotic cell 1.5-2 billion years ago [2]. In
most eukaryotes, mtDNA now primarily encodes a small,
but essential, subset of genes required for oxidative phos-
phorylation; for example, the human mtDNA molecule
harbors 37 genes (13 mRNAs specifying oxidative
phosphorlaytion subunits, 22 tRNAs and 2 rRNAs) [3]. The
proteins encoded in mtDNA are expressed in the
mitochondrion, but the complete mitochondrial proteome is
the product of two genomes, as most mitochondrial proteins
are transcribed from genes in the nucleus, translated by
cytoplasmic ribosomes, and imported into the organelle to
their sites of action. Interestingly, this nucleus-encoded
majority includes all the proteins needed to replicate
mtDNA and orchestrate its expression [3]; several of these
proteins have been implicated recently in human disease.
Hundreds of mutations in the mtDNA itself have also been
identified as the cause of a variety of maternally inherited
diseases. Furthermore, accumulation of mtDNA mutations
and deletions occurs in many tissues over time and are
thought to contribute to aging and age-related pathology [1].
After more than a century of intensive study, we know an
enormous amount about mitochondrial structure, function
and biogenesis. In the case of oxidative phosphorylation, for
example, the mechanism is understood in great detail [4]. The
ability of budding yeast to grow both aerobically and
anaerobically (without the need for oxidative phosphory-
lation) was instrumental in this success [5], along with a
multidisciplinary attack on the problem by a large number of
investigators using the tools of genetics, biochemistry,
biophysics, physiology, and cell and structural biology, as well
as information from the pathology of human mitochondrial
diseases.
Our understanding of mitochondrial function as a whole is
still far from complete, however. Null mutations in genes
required for mitochondrial protein import, for example,
result in a lethal phenotype in yeast and thus cannot be
studied in the same way as could the genes controlling
oxidative phosphorylation. More sophisticated analyses are
needed to fully define the mitochondrial proteome in yeast
and other organisms, and to define those factors that do not
reside in mitochondria but nonetheless affect their function.
Outstanding questions include how the structural dynamics
of mitochondria impact on their function, what signaling
pathways regulate mitochondrial function and coordinate
nuclear and mitochondrial gene expression, how mitochon-
drial biogenesis and activity are regulated in a tissue-specificfashion and, last but not least, what the full impact is of
mitochondrial dysfunction on human health. It is in these
contexts that more recent systematic approaches are having
a huge impact.
The integrative analysis of multiple datasets dealing with
different aspects of mitochondria is defining novel
functional relationships between genes and proteins in all
aspects of mitochondrial physiology, and has also identified
new mitochondrial disease loci. In a recent exemplary
example of such an analysis, Lars Steinmetz and colleagues
[6] have taken a machine-learning approach to construct the
most comprehensive version of the mitochondrial inter-
actome yet, using 24 complementary datasets covering various
aspects of mitochondrial proteomics and genomics in yeast
and other organisms. As we discuss here, their analysis will
help to advance the understanding of the mitochondrial
interactome on several fronts.
The integrative approach does, of course, rely heavily on
high-quality individual datasets, and for mitochondria there
is already a good foundation of systematic studies. Notable
among these are the global analysis of protein localization in
yeast using tagged open reading frames [7,8], the proteomic
analysis of purified mitochondria and mitochondrial
substructures using mass spectroscopy-based methods [9-
13], systematic analysis of the collections of yeast gene
knock-outs for mitochondrial related phenotypes [14,15],
and gene-expression profiling in conditions that require
mitochondrial function or when mitochondrial oxidative
phosphorylation is disrupted [16-23]. Several of these
studies provided critical datasets used by Perocchi et al. [6]
in their analysis. While each of these approaches provides
new and useful data, individually they can illuminate only a
limited part of the whole mitochondrial system - hence the
need for integrated analysis to achieve complete resolution
of the mitochondrial network.
Integrative analysis has already accelerated the cataloging of
mitochondria-related components and yielded new insights
into the mitochondrial system and its ties to human disease,
as the following few examples illustrate. Proteomic analysis
of mitochondria from different mouse tissues combined with
gene-expression profiling has shed light on the tissue
specificity of the mitochondrial proteome in mammals and
its regulation [10]. Combining gene-expression profiling and
proteomic data with genetic mapping facilitated the
identification of the gene LRPPRC as a disease locus for the
mitochondrial disorder Leigh Syndrome French-Canadian
type [24]; LRPPRC is thought to encode a protein involved
in mitochondrial gene expression [25]. Using the known
differences in the architecture of oxidative phosphorylation
among model organisms, a molecular chaperone required
for assembly of mitochondrial complex I has been identified
as the cause of progressive encephalomyopathy in humans
[26]. Through the simultaneous analysis of 8 genome-scale
datasets, 1,080 genes with a high probability of being
mitochondria-associated have been defined, including 368
not previously assigned as potentially relevant to mitochon-
drial function [27]. When combined with genetic mapping
data, this information enabled the gene MPV17 to be identi-
fied as a locus for a disease in the “mtDNA-depletion
syndrome” class [28], characterized by class of human
mitochondrial diseases characterized by a severe reduction
in the number of mtDNA molecules in specific tissues [29].
Perocchi et al. [6] have now taken integrative analysis even
further by combining information from 24 published data-
sets. They identified 895 proteins in what they call the
“mitochondrial system” of budding yeast, of which 13% have
a detectable α-proteobacterial ancestry and 60% have human
orthologs. Of particular interest, about two-thirds of the
mitochondrial proteins implicated in human disease have
orthologs in this yeast mitochondrial system; many of these
have a clear α-proteobacterial ancestry, a correlation that has
been documented previously [30]. Perocchi et al. [6] point
out that in many cases, deletion of the yeast ortholog of a
human mitochondrial disease gene results in a relatively mild
phenotypic change - rather than a lethal phenotype or the
‘petite’ phenotype seen when genes involved in oxidative
phosphorylation are knocked out [5]. In other words, genes
that are absolutely required for mitochondrial function in
yeast are poorly represented among human disease loci. This
is likely to be because loss-of-function mutations in the
orthologous human genes are probably incompatible with
development or survival in humans as well.
Using the program STRING [31], a search tool for retrieving
interacting genes, Perocchi et al. [6] generated an extensive
network of nearly 10,000 interactions. This is the most
comprehensive version of the yeast mitochondrial inter-
actome compiled so far and will advance our understanding
of mitochondrial function in various ways. First, the authors
were able to place groups of mitochondrial proteins into one
of 164 functional modules. This not only highlighted potential
novel functional interactions between known mitochondrial
proteins, but will also provide a framework for testing
hypotheses regarding members of the mitochondrial
proteome of unknown function. Second, as well as defining
interactions between mitochondrially localized proteins, the
mitochondrial interactome compiled by Perrochi et al. [6]
also implicates other cellular proteins and processes that are
not confined physically to the organelle but are still critical
for its function. This is not surprising, given the well-
documented dependence of mitochondria on signaling
pathways that connect the nucleus and mitochondria [32]
and the mitochondrial requirement for building blocks such
as nucleotides [33,34] and lipids that are synthesized
elsewhere in the cell. The new findings should, however,
provide new insights into precisely which signaling and
metabolic pathways are involved and how mitochondria are
regulated in concert with other cellular activities.
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Genome Biology 2007, 8:203With the current explosion in the availability of genome-wide
and systems data, the need for comprehensive integrated
analysis is clear. Such combinatorial analysis will need to mine
not only mitochondria-centric datasets, but also those that
examine other aspects of cell physiology at a global level, as
well as traditional data repositories such as disease databases,
evolutionary relationships and the vast literature. The recent
advances in our understanding of the mitochondrial proteome
and its interactions serve as an instructive paradigm for
related studies on other cellular organelles and processes.
And, as we have emphasized, clues to the pathology of human
disease are gained through the novel interactions and
potential links to function unearthed by these methods.
Perhaps most importantly, high-quality genome-scale analyses
and the subsequent comprehensive mining of all available
datasets help to accelerate experimental basic and biomedical
research by enabling the formulation of specific hypotheses
that can be tested directly using modern techniques. A
successful marriage of systematic information and hands-on
experimentation is the key to fully elucidating the complexities
of biological systems and mechanisms of disease.
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